My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iSpecimen Inc. - Common Stock (NQ:ISPC)

1.487 -0.063 (-4.08%)
Streaming Delayed Price Updated: 2:32 PM EDT, Sep 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about iSpecimen Inc. - Common Stock

Premarket Small-Caps Surge: PRSO, VEEE, HOUR, LOOP – More Stocks Inside
Via AB Newswire
iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions
Woburn, Massachusetts--(Newsfile Corp. - September 4, 2025) - iSpecimen Inc. (NASDAQ: ISPC), (the "Company"), a technology-enabled company modernizing the way... 
Via Newsfile
iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform
Woburn, Massachusetts--(Newsfile Corp. - August 21, 2025) - iSpecimen Inc. (NASDAQ: ISPC), an online marketplace for human biospecimens, today announced... 
Via Newsfile
iSpecimen’s Real Value: A Functioning Life Sciences Business Backed by a Planned $200M Digital Treasury (NASDAQ: ISPC)
Via AB Newswire
iSpecimen's $6M Valuation Doesn't Reflect the Business-Let Alone the $200M Treasury (NASDAQ: ISPC)
Via ACCESS Newswire
iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow
Woburn, Massachusetts--(Newsfile Corp. - August 7, 2025) - iSpecimen Inc. (NASDAQ: ISPC), a technology-enabled company modernizing the way human biospecimens... 
Via Newsfile
iSpecimen (NASDAQ: ISPC) Just Engineered A Game Changing Deal That Includes A $200 Million Treasury
Via AB Newswire
iSpecimen Defines $200M Strategy to Power Long-Term Growth (NASDAQ: ISPC)
Via ACCESS Newswire
iSpecimen (NASDAQ: ISPC): The $1.35 Biotech Quietly Engineering a $200M Financial Backbone
Via ACCESS Newswire
iSpecimen: The $1.35 Biotech Behind a $200M Growth Strategy ($ISPC)
Via AB Newswire
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
From iSpecimen Inc.
Via GlobeNewswire
iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market
From iSpecimen Inc.
Via GlobeNewswire
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
From iSpecimen Inc.
Via GlobeNewswire
Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
From iSpecimen Inc.
Via GlobeNewswire
iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
From iSpecimen Inc.
Via GlobeNewswire
iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
From iSpecimen Inc.
Via GlobeNewswire
iSpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering
Via AB Newswire
Topics Initial Public Offering
iSpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings
Via AB Newswire
Topics Initial Public Offering
iSpecimen Inc. Stocks 48% Premarket Surge On Thursday Ignited A Regular Session Rally
Via AB Newswire
Topics Initial Public Offering
RJD Green Inc. (OTC: RJDG) Stock Surges Amid Investor Interest on Record Revenues
Via AB Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.